No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Kamada Secures $25 Million Contract for Immune Globulin Products in Latin America
Kamada Announced That It Was Awarded a Contract With an International Organization for the Supply of KAMRAB and VARIZIG in Latin America for 2025-2027
Stifel Maintains Kamada(KMDA.US) With Buy Rating
Stifel Nicolaus Reaffirms Their Buy Rating on Kamada (KMDA)
Kamada Up Nearly 14%, on Track for Highest Close Since February 2021 -- Data Talk
Kamada Shares Rise 16% on Earnings Outlook, Trial Progress